Hostname: page-component-848d4c4894-xm8r8 Total loading time: 0 Render date: 2024-06-22T23:44:32.809Z Has data issue: false hasContentIssue false
  • English
  • Français

Local rifampicin in treatment of rhinoscleroma

Published online by Cambridge University Press:  29 June 2007

A. M. Gamea
A. M. Gamea
Affiliation:
Lecturer of Otolaryngology, ENT Department, Tanta University.
Get access Rights & Permissions [Opens in a new window]

Summary

Many antibiotics, chemotherapeutic agents and other chemicals have been tried in the treatment of scleroma without much success (Toppozada et al, 1967). The most popular of these drugs are streptomycin and aureomycin (Botros et al, 1954; Zwiefach, 1955; El-Mofty, 1962), terramycin and chloromycetin (Hoover and King, 1953) and ampicillin, septrin and vibramycin (Ssali, 1975).

El-Mofty and Attia (1957) attributed considerable value to the use of 20 per cent aureomycin ointment locally in treating the disease. Nigonol in the form of a local injection was tried by Toppozada et al. (1967) and they claimed good results. Shaer et al. (1981) reported that local application of 2 per cent acriflavine solution over an eight-week period was an effective and safe remedy for rhinoscleroma.

Rifampicin has been used systemically with success as a new antibiotic for the treatment of scleroma (Riad, 1982). The aim of the present study was to evaluate the response of rhinoscleroma to local medication with rifampicin.selected for this study. The cases were diagnosed by clinical, histopathological (Fig. 1) and bacteriological data. Twelve cases were in the atrophic stage while eighteen were in the granulomatous stage of the disease. Rifampicin was applied locally into the nose in two forms:

1. Nasal instillations: used mainly in the atrophic cases. One ampoule of rifampicin (Rifocin-Lepetit®) 125 mg. diluted in 20 ml. saline solution was used and 2 ml. of the solution was applied twice daily.

2. Nasal infiltration: used mainly in the granulomatous cases. One ampoule of rifampicin (Rifocin-Lepetit®) 125 mg. was infiltrated into the granulomas every other day.

Treatment was continued for eight weeks. Punch bio-spies were taken from the nasal lesions after four and eight weeks during the course of therapy and six months after the cessation of treatment. Biopsies were fixed, dehydrated, embedded in paraffin, sectioned and stained with H and E. Part of each specimen was submitted to bacteriological studies for the isolation of K. rhi-noscleromatis (Levine, 1951).

Type
Main Articles
Information
The Journal of Laryngology & Otology , Volume 102 , Issue 4 , April 1988 , pp. 319 - 321
Copyright
Copyright © JLO (1984) Limited 1988

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Botros, G., Hamilton, P., Floyd, T., Mufti, A. and Imam, A. (1954) Scleroma in Egypt. Annals of Otology, Rhinology and Laryngology, 63: 1031–1054.Google Scholar
El-Mofty, A. (1962) Histological examination of scleroma. Annals of Otology, Rhinology and Laryngology, 71: 377–381.Google Scholar
El-Mofty, A. and Attia, O. (1957) The treatment of rhinoscleroma locally with aureomycin. Annals of Otology, Rhinology and Laryngology, 66: 994–1001.CrossRefGoogle ScholarPubMed
Hoover, W. and King, G. (1953) Rhinoscleroma, case report. Archives of Otolaryngology, 57: 79–82.CrossRefGoogle Scholar
Levine, M. (1951) Scleroma. American Journal of Clinical Pathology, 21: 546–549.Google Scholar
Riad, G. (1982) Comparative study of the effects of rifampicin, tetracycline and combined rifampicin with tetracycline on rhinoscleroma. Thesis, Tanta University, Egypt.Google Scholar
Shaer, M., Rizk, M., Shawaf, I., Ali, M. and Hashash, M. (1981) Local acrifiavine: A new therapy for rhinoscleroma. Journal of Laryngology and Otology, 95: 701–706.CrossRefGoogle Scholar
Ssali, C. (1975) The management of rhinoscleroma. Journal of Laryngology and Otology, 89: 91–99.CrossRefGoogle ScholarPubMed
Toppozada, H., Mazloum, H., Khalil, H., Geundi, A. and El-Dakhakhny, M. (1967) The effect of nigonol on rhinoscleroma. The 5th International Congress of Chemotherapy, Vienna, Austria, pp. 633–644.Google Scholar
Zwiefach, E. (1955) Rhinoscleroma. Journal of Laryngology and Otology, 69: 321–330.CrossRefGoogle ScholarPubMed